Remission of diabetes mellitus type 2 with severe hyperglycemia after Exenatide treatment

Diabetes Research and Clinical Practice

Volumn 90, Issue 3, 2010, Pages

  Al Jebawi, Ahmed F ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUBAI HEALTH AUTHORITY   (United Arab Emirates)

Author keywords

Cure; Diabetes; Exenatide; GLP 1; Incretin; Remission

Indexed keywords

EXENDIN 4; GLIMEPIRIDE; GLUCOSE; HEMOGLOBIN A1C; METFORMIN; ORAL ANTIDIABETIC AGENT; ROSIGLITAZONE;

ADULT; ARTICLE; BULIMIA; CASE REPORT; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PSYCHOSOCIAL CARE; REMISSION; SIDE EFFECT; SWEATING; TREMOR; WEIGHT CONTROL; WEIGHT REDUCTION;

DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; METFORMIN; MIDDLE AGED; OBESITY; PEPTIDES; REMISSION INDUCTION; SULFONYLUREA COMPOUNDS; THIAZOLIDINEDIONES; VENOMS; WEIGHT LOSS;

EID: 78649471908     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.09.018     Document Type: Article

References (11)

1. Alexandrides T.K., Skroubis G., Kalfarentzos F. Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity. Obes Surg 2007, 17:176-184.
2. Sjostrom L., Lindroos A.K., Peltonen M. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004, 351:2683-2693.
3. Wittgrove A.C., Clark G.W. Laparoscopic gastric bypass, Roux-en-Y-500 patients: technique and results, with 3-60 month follow-up. Obes Surg 2000, 10:233-239.
4. Schauer P.R., Burguera B., Ikramuddin S. Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003, 238:467-484.
5. Pories W.J., Swanson M.S., MacDonald K.G. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995, 222:339-350. [discussion 350-332].
6. Martins C., Strømmen M., Stavne O.A., Nossum R., Mårvik R., Kulseng B. Bariatric surgery versus lifestyle interventions for morbid obesity-changes in body weight, risk factors and comorbidities at 1 year. Obes Surg 2010, (April 9). [Epub ahead of print].
7. Rubino F., Gagner M., Gentileschi P. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 2004, 240:236-242.
8. Rubino F., Gagner M. Potential of surgery for curing type 2 diabetes mellitus. Ann Surg 2002, 236:554-559.
9. David D.P., Bradley D.P., Kulstad R., Schoeller D.A. Exenatide and weight loss. Nutrition 2010, 26:243-249.
10. Primeaux S.D., Barnes M.J., Braymer H.D., Bray G.A. Sensitivity to the satiating effects of exendin 4 is decreased in obesity-prone Osborne-Mendel rats compared to obesity-resistant S5B/Pl rats. Int J Obes 2010, (1-7 April 20). [Epub ahead of print].
11. Verdich C., Toubro S., Buemann B., Lysgard M.J., Juul H.J., Astrup A. The role of postprandial releases of insulin and incretin hormones in meal-induced satiety-effect of obesity and weight reduction. Int J Obes Relat Metab Disord 2001, 25:1206-1214.